Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy.

Autor: Navarro-Becerra JA; Mechanical Engineering Department, University of Colorado Boulder, Boulder, CO 80309, USA., Borden MA; Mechanical Engineering Department, University of Colorado Boulder, Boulder, CO 80309, USA.; Biomedical Engineering Program, University of Colorado Boulder, Boulder, CO 80309, USA.
Jazyk: angličtina
Zdroj: Pharmaceutics [Pharmaceutics] 2023 May 30; Vol. 15 (6). Date of Electronic Publication: 2023 May 30.
DOI: 10.3390/pharmaceutics15061625
Abstrakt: Microbubbles are 1-10 μm diameter gas-filled acoustically-active particles, typically stabilized by a phospholipid monolayer shell. Microbubbles can be engineered through bioconjugation of a ligand, drug and/or cell. Since their inception a few decades ago, several targeted microbubble (tMB) formulations have been developed as ultrasound imaging probes and ultrasound-responsive carriers to promote the local delivery and uptake of a wide variety of drugs, genes, and cells in different therapeutic applications. The aim of this review is to summarize the state-of-the-art of current tMB formulations and their ultrasound-targeted delivery applications. We provide an overview of different carriers used to increase drug loading capacity and different targeting strategies that can be used to enhance local delivery, potentiate therapeutic efficacy, and minimize side effects. Additionally, future directions are proposed to improve the tMB performance in diagnostic and therapeutic applications.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje